Pages that link to "Q28081992"

The following pages link to PI3K mutations in breast cancer: prognostic and therapeutic implications (Q28081992):

Displaying 44 items.

• The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review) (Q26799398) (← links)
• Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study (Q35801713) (← links)
• Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells (Q36311216) (← links)
• Over-Expression of POU Class 1 Homeobox 1 Transcription Factor (Pit-1) Predicts Poor Prognosis for Breast Cancer Patients (Q37391678) (← links)
• Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis (Q37708928) (← links)
• Clinical outcomes based on multigene profiling in metastatic breast cancer patients (Q37718221) (← links)
• A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy (Q37741425) (← links)
• Molecular characterization of breast cancer cell lines through multiple omic approaches. (Q38701221) (← links)
• Integrative gene set enrichment analysis utilizing isoform-specific expression (Q38744262) (← links)
• The PI3K Pathway: Background and Treatment Approaches (Q39147158) (← links)
• Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes. (Q39638185) (← links)
• A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer (Q41661081) (← links)
• Frequent detection of PIK3CA mutations in single circulating tumor cells of patients suffering from HER2-negative metastatic breast cancer (Q41763224) (← links)
• Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer (Q47097388) (← links)
• Serial-omics of P53-/-, Brca1-/- Mouse Breast Tumor and Normal Mammary Gland (Q47135102) (← links)
• Metastatic HER2 Breast Cancer: A Potentially Curable Disease? (Q47161064) (← links)
• Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. (Q47564750) (← links)
• Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2 primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). (Q47782850) (← links)
• Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges (Q49887925) (← links)
• PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors. (Q52403252) (← links)
• A simple and robust real-time qPCR method for the detection of PIK3CA mutations. (Q52727509) (← links)
• A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective PI3Kα Isoform Inhibitor, in Patients with Advanced Solid Malignancies. (Q53301776) (← links)
• PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer. (Q55001013) (← links)
• Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer. (Q55466158) (← links)
• MGOGP: a gene module-based heuristic algorithm for cancer-related gene prioritization. (Q55487442) (← links)
• Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches (Q56889396) (← links)
• Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis (Q57112840) (← links)
• Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer (Q57284279) (← links)
• Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer (Q58797604) (← links)
• Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood (Q59812757) (← links)
• PIK3CA Mutational Status Is Associated with High Glycolytic Activity in ER /HER2- Early Invasive Breast Cancer: a Molecular Imaging Study Using [18F]FDG PET/CT. (Q64981395) (← links)
• Collaborative intra-tumor heterogeneity detection (Q90064905) (← links)
• RUNX1-dependent mechanisms in biological control and dysregulation in cancer (Q90265629) (← links)
• Genomic alterations associated with HER2  breast cancer risk and clinical outcome in response to trastuzumab (Q90393213) (← links)
• Relationship Between PIK3CA Amplification and P110α and CD34 Tissue Expression as Angiogenesis Markers in Iranian Women with Sporadic Breast Cancer (Q91665761) (← links)
• Somatic Mutation of PIK3CA (H1047R) Is a Common Driver Mutation Hotspot in Canine Mammary Tumors as Well as Human Breast Cancers (Q92013755) (← links)
• Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER breast cancer models resistant to CDK4/6 inhibitors (Q92091423) (← links)
• Helical and kinase domain mutations of PIK3CA, and their association with hormone receptor expression in breast cancer (Q92564711) (← links)
• New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach (Q92733309) (← links)
• The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR /HER2- Metastatic Breast Cancer: Biological Mechanisms and New Treatments (Q92874803) (← links)
• Co-culture With Human Breast Adipocytes Differentially Regulates Protein Abundance in Breast Cancer Cells (Q92994088) (← links)
• A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR /HER2- Metastatic Breast Cancer (Q97422538) (← links)
• Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients (Q97645874) (← links)
• The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells (Q100415901) (← links)